They present realistic, complex, and contextually rich situations and often involve a dilemma, conflict, or problem that one or more of the characters in the … Claim this listing for free. ZS PHARMA, INC. was registered on Oct 06, 2016 as a stock type company located at 1100 PARK PL STE 300, SAN MATEO, CA 94403 . UNCLAIMED . © 2021 BioCentury Inc. All Rights Reserved. AZ gained ZS-9 through its $2.7 billion acquisition of, ...24, 2016 ). From manufacturing to technology to people, ZS Pharma is thinking differently about developing therapies to address unmet needs. Zs Pharma, Inc. Notifications des registres des douanes des États-Unis d’Amérique disponibles for Zs Pharma, Inc.. Voir leurs importations passées de Gl Filtration Ltd, un … It develops treatment of hyperkalemia. Company is located in the register with the Company number E0451012016-8 and with the national number of State Nevada NV20161608955.This legal entity was firstly registered on 12th October 2016 under the legal form of Foreign Corporation. ZS Pharma was founded in 2008, became a public company in 2014 and, in December 2015, joined the AstraZeneca Group. Pharmaceutical & Biotechnology ZS Pharma was founded in 2008, became a public company in 2014 and, in December 2015, joined the AstraZeneca Group. Clinical News. AZ gained the product in 2015 through its $2.7 billion acquisition of. ZS Pharma … Business Address: 508 WRANGLER DRIVE, SUITE 100 COPPELL, TX 75019: State of Incorp. Registered office street address is 1999 BRYAN ST. SUITE 900 DALLAS, TX 75201. Institutional Owners Top Mutual Funds Top ETFs Buyers Sellers. The incorporation date of this company is on 6th October 2016 and its headquarters can be found at 1100 PARK PL STE 300, SAN MATEO, CA, 94403. Owners who claim their business can update listing details, add photos, respond to reviews, and more. $52.04. ZS Pharma, founded in 2008, is a publicly traded biopharmaceutical company dedicated to challenging the status quo in disease states where therapeutic options have been limited. Zs Pharma, Inc. Overview. ZS Pharma, Inc is primarely in the business of pharmaceutical preparations. ZS Pharma, Inc. is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware. ZS PHARMA, INC. is an entity registered at Indiana with company number 2013112000524. Monthly Subscription. The company valuation of ZS Pharma, Inc, according to these metrics is way below the market valuation of its peer group. This business is unclaimed. Small Cap Basic. Votre image est trops volumineuse. ZS Pharma was founded in 2008, became a public company in 2014 and, in December 2015, joined the AstraZeneca Group. Insiders . Max 1Mo, Je déclare être actionnaire de la société concernée, Wall Street finit peu changée, la hausse des taux se précise, Wall Street ouvre hésitante après les chiffres de l'emploi, AstraZeneca achète ZS Pharma pour 2,7 milliards de dollars, Wall Street ouvre en baisse, la prudence s'impose avant la Fed, Les valeurs à suivre sur les marchés américains, Les valeurs à suivre aujourd'hui à Wall Street - Vendredi 11 septembre 2015, Actelion discute avec la biotech américaine ZS Pharma, Wall Street finit en hausse, Apple en soutien, Actelion a fait une offre sur ZS Pharma en août-presse, AstraZeneca potassium drug delayed by manufacturing snag, AstraZeneca buys most of Acerta for $4 billion to add cancer drug, AstraZeneca chases Acerta to secure next cancer drug winner, Chief Human Resources & Administration Officer. ZS-9 regulatory update...other ions throughout the GI tract. ZS is a professional services firm that works side by side with companies to help develop and deliver products that drive customer value and company results. Suivez toute l'actualité de ZS PHARMA, INC., les communiqués, analyses et rapports financiers, les enjeux économiques pour cette valeur côtée à la Bourse de Nasdaq, et bien plus encore ! $33.03. We are a biopharmaceutical company dedicated to challenging the status quo in disease areas where therapeutic options have been limited.... more ZS Pharma, Inc. engages in the development of development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. Insider Trades. ZS Pharma Inc (ZS Pharma), a subsidiary of AstraZeneca Plc is a biopharmaceutical company that develops and markets non-absorbed drugs to treat renal, … Allakos sustains its gains on strength of GI readout, Big gain for Allakos as first-in-class GI program heads toward pivotal phase, Third time's the charm for AZ hyperkalemia drug, Third timeâs the charm for AZ hyperkalemia drug, AstraZeneca hyperkalemia therapy gets EU approval, Management tracks: Cerecor, Allakos, Epizyme, Merrimack, FDA issues second CRL for AZ's hyperkalemia candidate. ZS PHARMA, INC. MINNESOTA BUSINESS CORPORATION (FOREIGN) WRITE REVIEW: Address: 1010 Dale St N Saint Paul, MN 55117-5603: Registered Agent: CT Corporation System Inc. Filing Date: October 05, 2016: File Number: 906173200027: Contact Us About The Company Profile For Zs Pharma, Inc. We are a … The agent name of this company is: C T CORPORATION SYSTEM , and company's status is listed as Active now. The Company produces non-absorbed drugs to treat cardiovascular, renal, liver, and metabolic diseases. Et puisque le marché est la référence, le bêta du marché est toujours 1. ZS Pharma, Inc. develops and distributes pharmaceutical products. BioCentury | Mar 17, 2017. Zs Pharma, Inc. filed as a Foreign For-Profit Corporation in the State of Texas on Monday, June 15, 2009 and is approximately eleven years old, according to public records filed with Texas Secretary of State.A corporate filing is called a foreign filing when an existing corporate entity files in a state other than the state they originally filed in. The N/A ratio of ZS Pharma, Inc, is significantly lower than the average of its sector (Pharmaceuticals): 3.33. Jan 10, 2015 #1 Case studies are stories. You can find this business by geo coordinates: 39° 44' 57.7" N , 75° 38' 36" W. Both come from, ...other ions throughout the GI tract. © 2021 BioCentury Inc. All Rights Reserved. Monthly Subscription. Company is located in the register under the national Company number 1218662. 508 Wrangler Drive # 100 Coppell, TX 75019 . ZS Pharma was founded in 2008, became a public company in 2014 and, in December 2015, joined the AstraZeneca Group. ZS PHARMA, INC. Stock Price . ZS Pharma, Inc. - Case Study | Case Studies | Business Case Study. BioCentury | Mar 22, 2017. Recent... | … Founder of ZS Pharma, Inc. and Renibus Therapeutics, Inc., Alvaro F. Guillem currently occupies the position of Chairman & Chief Executive Officer at Renibus Therapeutics, Inc., Chairman at OncoNano Medicine, Inc. and President of ZS Pharma, Inc. for only. for only. ZSPH / ZS Pharma, Inc. (98979G105) CIK: 1459266: Overview; Ownership . The company valuation of ZS Pharma, Inc, according to these metrics is way below the market valuation of its sector. Thread starter shahjagruti16; Start date Jan 10, 2015; Tags business case pharma studies study; S. shahjagruti16 MP Guru. AstraZeneca plc (LSE:AZN; NYSE:AZN) acquired ZS Pharma... Read More. 17 - Material Contract - Accession Number 0001193125-14-199541 - Filing - SEC Free trial . We connect the dots across organizations leveraging analytics, technology and strategy to deliver solutions to the most difficult business challenges. REDWOOD CITY, Calif., Aug. 6, 2015 -- ZS Pharma, Inc. , today reported its financial results for the second quarter ended June 30, 2015, and provided an overview of recent accomplishments. Reviews from ZS Pharma, Inc. employees about ZS Pharma, Inc. culture, salaries, benefits, work-life balance, management, job security, and more. AZ gained ZS-9 through its $2.7 billion acquisition of, ...Carlos, Calif.) named Robert Alexander CEO and Adam Tomasi COO and CFO. Both come from ZS Pharma Inc.....CEO and Tomasi was CSO and head of corporate development. ZS PHARMA, INC. is a business legal entity registered in compliance with the national legislation of the State of Connecticut under the legal form of Stock. It also focuses on clinical development, novel technology, and clinical trials. AZ gained ZS-9 through its $2.7 billion acquisition of ZS Pharma Inc.... Read More. Current status of the company is Active. Company News. The company was founded by Alvaro F. Guillem and Donald J Zs Pharma, Inc. has … 89.98 0.00 (0.0%) Upgrade to Real-Time Afterhours (Closed) Best deals to access real time data! Big Cap Pro. ZS Pharma, Inc. - IPO: ‘S-1’ on 5/14/14 - EX-10.18 Registration Statement (General Form) - Seq. Company is incorporated on19th November 2013. ZS PHARMA, INC. mailing address is PO BOX 15437 WILMINGTON, DE 19850-5437. Follow ZSPH. ZS Pharma is dedicated to challenging the status quo in disease states where therapeutic options have been limited. Zs Pharma, Inc. UNCLAIMED . He is also on the board of Nanoscope Therapeutics, Inc. ZS PHARMA, INC. (ZSPH) financial statements (2021 and earlier) Company profile. The company's agentis CT CORPORATION SYSTEM, 150 WEST MARKET STREET, SUITE 800, INDIANAPOLIS, IN, 46204, USA The company's ceois ALVARO GUILLEM, PH.D., 508 WRANGLER DR, STE 100, COPPELL, TX, 75019, USA Business company ZS PHARMA, INC. is a legal entity registered under the law of State Nevada. AZ gained the drug through its $2.7 billion acquisition of, ...was "compliant with good manufacturing practice." Terms & Conditions | Privacy Policy, ...management includes several members of the team, including CEO Robert Alexander, that sold hyperkalemia company, ...Several members of Allakos' team, including CEO Robert Alexander, were among management at hyperkalemia company, ...ions throughout the GI tract. Free trial. Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB. ZS PHARMA INC : Cours de bourse, graphiques, cotations, conseils boursiers, données financières, analyses et actualités en temps réel de l'action ZS PHARMA INC | Nasdaq Bêta endetté / Bêta désendetté de ZS Pharma, Inc, (ZSPH | USA) Le bêta est une mesure statistique qui compare la volatilité d'une valeur à la volatilité du marché, typiquement mesurée par un indice de marché de référence. For financial reporting, their fiscal year ends on December 31st.
Big Boss Jokes, 14 Zloty In Euro, Satisfactory Scan For Hard Drive, Die Bachelorette 2020 Kandidaten, Hamburger Sportbund Aktuell, Once Upon A Time Lyrics Deutsch,